ArticleJournal of shoulder and elbow arthroplasty2025
Administration of Perioperative Tranexamic Acid and Range of Motion After Total Shoulder Arthroplasty.
Article in Journal of shoulder and elbow arthroplasty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tranexamic acid in shoulder surgery: a narrative review.JSES reviews, reports, and techniques · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tranexamic Acid (TXA) has been associated with improved range of motion (ROM) in knee arthroplasty literature. The primary aim of this study is to assess the association between perioperative TXA in Total Shoulder Arthroplasty (TSA) and ROM up to 12-months postoperatively. The authors hypothesized there would be no difference between groups. Methods: A single-institution retrospective cohort study of patients who underwent TSA between 2012-2022 was performed. Shoulder ROM was recorded pre-operatively, 3-months, 6-months, and 9-12-months postoperatively. Secondary outcomes including blood loss, transfusions, pain scores, and 90-day complications were collected. Statistical analyses were performed using STATA/SE. Results: A total of 551 TSAs were included. Pre-operative elevation was greater in the TXA group (90.1° vs 74.0°, Conclusion: Patients who received perioperative TXA had significantly improved elevation at 6-months following TSA compared to controls. The results suggest there may be a link between postoperative ROM and TXA in TSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.